Asaigermanium and cancer 1

By Dr. Nakamura Atsushi M.D.

Earlier, I wrote that Asaigermanium (Ge-132) has been shown to be effective against cancer at the cellular level and in animal studies, but there is little evidence of its effectiveness in humans. But later on, I read “Germanium: The health and life enhancer” (author Sandra Goodman) and found that there were several studies, including the RCT (randomized controlled trial). Let me introduce it here.

A trial to evaluate the efficacy of Ge-132 in patients with inoperable lung cancer.
A double-blind study was performed to randomly assign patients into chemotherapy + Ge-132 group and chemotherapy + placebo group.
Check items were, life expectancy, tumor diameter, QOL (quality of life), and immunological markers were evaluated.
Statistically, Ge-132 administration resulted in significant improvements in all checked items.
Reference: “Some pharmacological and clinical aspects of a novel aspects of a organic germanium compound Ge-132” (Mizushima at al. 1984)

Studies of administering Sanumgerman (germanium lactate citrate, an organic germanium compound developed by Sanum-Kehibeck, West Germany) to ovarian cancer patients.
6 women (aged 44 to 64) who had ovaries and uterus removed due to ovarian cancer were treated with Sanumgerman to determine postoperative health, pain, and properties of the wound.
All 6 patients had significant improvement in health and reduced pain. 5 of the 6 patients did not accumulate exudates in the abdomen and in the Douglas cavum. Slight accumulation was noted in only 1 person.
Reference: “Experience with Sanumgerman in Poland and Germany” (Samochowiec et al. 1984)

A study of Spirogermanium (an organic germanium compound synthesized by team of Rice of Smith Kline, which has been shown to have anticancer and antiarthritic effects but is neurotoxic) to cancer patients, Phase 1. (This is to confirm safety, not verification of treatment effect).
35 cancer patients (of various types of cancer) were administered Spirogermanium intravenously.  Some patients had mild side effects, such as dizziness, but all were resolved within minutes to few hours. No side effects such as toxicity due to accumulation or myelosuppression were observed.
Phase 2 (to verify efficacy of treatment), Spirogermanium was administered to patients with lymphoma (non-Hodgkin’s lymphoma and Hodgkin’s disease).  5 (30%) out of 17 patients had objectively improved symptoms and 2 had remission. Hematological toxicity was not seen.
Reference: “The clinical pharmacology of Spirogermanium, a unique anticancer agent” (Schein et al. 1984)

Case reports seen are the following.
1. Oral administration of Sanumgerman to a 62-year-old female with myeloproliferative disorder showed reduction in splenic tumor in 3 weeks.
Reference: “Biophysical results with germanium and Sanumgerman” (Kokoschinegg et al. 1984)

2. A 18-year-old male with embryonal carcinoma of the testis and lungs was treated with various chemotherapy treatments with Sanumgerman, and found significant improvement, as of current 1985, there is no metastisis.
Reference: “Experience with Sanumgerman in Poland and Germany” (Samochowiec et al. 1984)

3. A 55-year-old female who had undergone surgery for cancer had metastasis of the stomach, kidney, mesentery, and liver. After receiving chemotherapy treatment, he started taking Sanumgerman. Changes in symptoms, including blood analysis were closely monitored. Four years after the operation, the metastatic lesion in the liver was gone. However, there was slight enlargement of the lymph nodes was seen.
Reference: “Case study: adenocarcinoma with liver metastases” (Paetz et al. 1984)

4. Surgery was performed in 1978 and 1979 for colorectal cancer in a 78-year-old male. Since the metastasis in the liver was found, he began taking Sanumgerman along with a strict diet to fight the cancer. No metastasis has been found after 4 years.
Reference: “The Sanumgerman therapy in biological medicine” (Zoubek et al. 1984)

5. A 54-year-old male with right lung cancer was treated with chemotherapy drug. However, loss of appetite, energy, and physical strength were seen.  He started taking Ge-132 500mg/day. After 5 months, the cancer disappeared, had no more dry cough, and was in better shape.

The disadvantage of all the data is that it is an old book published back in 1988.
In addition, there is an RCT with a combination of Asaigermanium and chemtherapy drug, but no RCT with Asaigermanium alone cannot be found.
In terms of tumor size reduction, chemotherapy drugs may be effective. But how is it in the long term? Chemotherapy drugs are rather unnecessary, and “I think” it is more likely that treatment with Asaigermanium alone will have a better long-term prognosis. I can only say “I think” since there is no RCT(randomized control trial).

Even without the RCT, as noted above, there are number of cases reported showing the efficacy. Even after looking at this report, Asaigermanium (organic germanium) should not be criticized as a “zero-evidence folk remedy.”
In fact, Dr. Kazuhiko Asai wanted to have the country approve Asaigermanium as a chemotherapy drug. But that thought never came true. why? It is more for political and economic reasons than for the denying the effectiveness of Asaigermanium.  So, of course, it works.  Use it together with high-concentration vitamin C infusion, and also take alpha lipoic acid, coenzyme Q10, and vitamin K2 together.
Don’t be afraid to get cancer. It’s important to know that there are other options, rather than jumping on the chemotherapy treatment as the doctor says.

Above is the English translation of an article by Dr. Nakamura Atsushi. For original article in Japanese language click here